What is Ipsen (IPN)?
Ipsen is a global biopharmaceutical company specializing in the development, manufacturing, and marketing of innovative medicines. The company focuses on areas such as oncology, neuroscience, and rare diseases, aiming to address unmet medical needs through its portfolio of therapies. Ipsen operates research and development facilities alongside manufacturing sites, supporting its commitment to scientific innovation and quality production. The company has established a presence in multiple countries, facilitating access to its treatments worldwide. Ipsen collaborates with academic institutions, biotechnology firms, and other pharmaceutical companies to advance its research pipeline and expand therapeutic options. Its product range includes both proprietary drugs and licensed products, reflecting a diversified approach to healthcare solutions. Ipsen's organizational structure supports integrated efforts across research, clinical development, regulatory affairs, and commercial operations, enabling it to navigate the complexities of the pharmaceutical industry. The company is recognized for its contributions to medical science and its role in improving patient outcomes through targeted therapies.
Ipsen Stock Price Today: Live Overview
The price today is shaped by active trading, as Ipsen stands at €152.56. Throughout the day, it has moved between €151.74 and €154.84, marking a daily change of 0%.
FAQ: Ipsen (IPN)
What is the current price of IPN stock?
Ipsen's current market price is €152.56.
Does IPN pay dividends?
Ipsen pays dividends via cash distributions (if applicable).
Does IPN have a formal corporate presence or regional headquarters in the UAE?
Ipsen does not have an official regional office or subsidiary in the UAE and operates through partners.
What is IPN best known for?
Ipsen is most famous for its biopharmaceutical products.
What assets are typically shown together with IPN?
Commonly shown alongside IPN: iBio, Inc., Assembly Biosciences, Inc., BioMarin
Latest shares articles



